Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17465
Country/Region: Eswatini
Year: 2015
Main Partner: John Snow, Inc
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $5,526,824 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $405,851
Care: TB/HIV (HVTB) $149,680
Care: Pediatric Care and Support (PDCS) $225,586
Testing: HIV Testing and Counseling (HVCT) $93,544
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $130,989
Treatment: Adult Treatment (HTXS) $4,266,083
Treatment: Pediatric Treatment (PDTX) $255,091
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 48
CARE_CURR Age/sex: <1 Male 2016 54
CARE_CURR Age/sex: 1-4 Female 2016 4
CARE_CURR Age/sex: 1-4 Female 2016 348
CARE_CURR Age/sex: 1-4 Male 2016 2
CARE_CURR Age/sex: 1-4 Male 2016 312
CARE_CURR Age/sex: 10-14 Female 2016 1
CARE_CURR Age/sex: 10-14 Female 2016 387
CARE_CURR Age/sex: 10-14 Male 2016 393
CARE_CURR Age/sex: 15-19 Female 2016 22
CARE_CURR Age/sex: 15-19 Female 2016 1,414
CARE_CURR Age/sex: 15-19 Male 2016 235
CARE_CURR Age/sex: 20-24 Female 2016 79
CARE_CURR Age/sex: 20-24 Female 2016 5,015
CARE_CURR Age/sex: 20-24 Male 2016 32
CARE_CURR Age/sex: 20-24 Male 2016 664
CARE_CURR Age/sex: 25-49 Female 2016 202
CARE_CURR Age/sex: 25-49 Female 2016 20,456
CARE_CURR Age/sex: 25-49 Male 2016 293
CARE_CURR Age/sex: 25-49 Male 2016 11,632
CARE_CURR Age/sex: 5-9 Female 2016 2
CARE_CURR Age/sex: 5-9 Female 2016 365
CARE_CURR Age/sex: 5-9 Male 2016 1
CARE_CURR Age/sex: 5-9 Male 2016 371
CARE_CURR Age/sex: 50+ Female 2016 14
CARE_CURR Age/sex: 50+ Female 2016 3,807
CARE_CURR Age/sex: 50+ Male 2016 16
CARE_CURR Age/sex: 50+ Male 2016 2,817
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 7
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 1,147
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 3
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,130
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 317
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 30,694
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 341
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 15,347
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 668
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 48,318
CARE_CURR Sum of Age/Sex disaggregates 2016 668
CARE_CURR Sum of Age/Sex disaggregates 2016 48,318
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 668
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 48,318
CARE_NEW Age/sex: <1 Female 2016 5
CARE_NEW Age/sex: <1 Male 2016 5
CARE_NEW Age/sex: 1-4 Female 2016 23
CARE_NEW Age/sex: 1-4 Male 2016 25
CARE_NEW Age/sex: 10-14 Female 2016 18
CARE_NEW Age/sex: 10-14 Male 2016 22
CARE_NEW Age/sex: 15-19 Female 2016 162
CARE_NEW Age/sex: 15-19 Male 2016 8
CARE_NEW Age/sex: 20-24 Female 2016 579
CARE_NEW Age/sex: 20-24 Male 2016 79
CARE_NEW Age/sex: 25-49 Female 2016 1,243
CARE_NEW Age/sex: 25-49 Male 2016 777
CARE_NEW Age/sex: 5-9 Female 2016 16
CARE_NEW Age/sex: 5-9 Male 2016 21
CARE_NEW Age/sex: 50+ Female 2016 264
CARE_NEW Age/sex: 50+ Male 2016 141
CARE_NEW Aggregated Age/sex: <15 Female 2016 63
CARE_NEW Aggregated Age/sex: <15 Male 2016 73
CARE_NEW Aggregated Age/sex: 15+ Female 2016 2,247
CARE_NEW Aggregated Age/sex: 15+ Male 2016 1,005
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 3,388
CARE_NEW Sum of Age/sex disaggregates 2016 3,388
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,388
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,388
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 157
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 125
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 1,291
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 360
HTS_TST By Test Result: Negative 2016 1,594
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 1,933
HTS_TST Sum of Aggregated Age/Sex <15 2016 282
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 1,651
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 1,933
HTS_TST Sum of Test Result disaggregates 2016 1,933
HTS_TST_POS By Test Result: Positive 2016 339
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 1,678
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 1,535
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 866
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 669
PMTCT_ARV Sum of New and Current disaggregates 2016 1,535
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 2,619
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 296
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 2,915
PMTCT_EID Sum of Infant Age disaggregates 2016 2,915
PMTCT_STAT By: Known positives at entry 2016 1,237
PMTCT_STAT By: Number of new positives identified 2016 443
PMTCT_STAT Number of new ANC and L&D clients 2016 5,122
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 4,872
PMTCT_STAT Sum of Positives Status disaggregates 2016 1,680
TB_SCREEN Age: <1 2016 75
TB_SCREEN Age: 1-4 2016 590
TB_SCREEN Age: 10-14 2016 1,066
TB_SCREEN Age: 15-19 2016 942
TB_SCREEN Age: 5-9 2016 979
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 2,712
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 39,851
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 668
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 48,318
TB_SCREEN Sex: Female 2016 27,660
TB_SCREEN Sex: Male 2016 14,902
TB_SCREEN Sum of Age disaggregates 2016 42,563
TB_SCREEN Sum of Aggregated Age disaggregates 2016 42,563
TB_SCREEN Sum of Sex disaggregates 2016 42,562
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 42,563
TX_CURR Age/Sex: <1 Female 2016 36
TX_CURR Age/Sex: <1 Male 2016 38
TX_CURR Age/Sex: 1-4 Female 2016 2
TX_CURR Age/Sex: 1-4 Female 2016 297
TX_CURR Age/Sex: 1-4 Male 2016 1
TX_CURR Age/Sex: 1-4 Male 2016 259
TX_CURR Age/Sex: 5-14 Female 2016 2
TX_CURR Age/Sex: 5-14 Female 2016 697
TX_CURR Age/Sex: 5-14 Male 2016 1
TX_CURR Age/Sex: 5-14 Male 2016 691
TX_CURR Aggregated Age/Sex: <1 Female 2016 36
TX_CURR Aggregated Age/Sex: <1 Male 2016 38
TX_CURR Aggregated Age/Sex: 15+ Female 2016 26,576
TX_CURR Aggregated Age/Sex: 15+ Male 2016 13,490
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 515
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 42,084
TX_CURR Sum of age/sex disaggregates 2016 42,084
TX_CURR Sum of Age/Sex disaggregations 2016 515
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 2,018
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 40,066
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 40,066
TX_NEW Aggregated Grouping by Age: <1 Male 2016 5
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 4
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 3,691
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 1,656
TX_NEW By Age/Sex: <1 Female 2016 6
TX_NEW By Age/Sex: <1 Male 2016 6
TX_NEW By Age/Sex: 1-4 Female 2016 41
TX_NEW By Age/Sex: 1-4 Male 2016 43
TX_NEW By Age/Sex: 10-14 Female 2016 27
TX_NEW By Age/Sex: 10-14 Male 2016 32
TX_NEW By Age/Sex: 15-19 Female 2016 267
TX_NEW By Age/Sex: 15-19 Male 2016 13
TX_NEW By Age/Sex: 20-24 Female 2016 967
TX_NEW By Age/Sex: 20-24 Male 2016 122
TX_NEW By Age/Sex: 25-49 Female 2016 2,080
TX_NEW By Age/Sex: 25-49 Male 2016 1,315
TX_NEW By Age/Sex: 5-9 Female 2016 24
TX_NEW By Age/Sex: 5-9 Male 2016 30
TX_NEW By Age/Sex: 50+ Female 2016 381
TX_NEW By Age/Sex: 50+ Male 2016 206
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 5,561
TX_NEW Sum of Age/Sex disaggregates 2016 5,560
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 5,347
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 4,292
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 4,928
Cross Cutting Budget Categories and Known Amounts Total: $815,000
Human Resources for Health $150,000
Food and Nutrition: Policy, Tools, and Service Delivery $200,000
Gender: Gender Based Violence (GBV) $75,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Gender: Gender Equality $100,000
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Capacity building
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Motor Vehicles: Purchased $290,000